nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—FPGS—Metabolism of folate and pterines—MTHFR—osteoporosis	0.0327	0.143	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—ATIC—osteoporosis	0.0184	0.0804	CbGpPWpGaD
Raltitrexed—Pemetrexed—ATIC—osteoporosis	0.0132	0.35	CrCbGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.0131	0.0574	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.0116	0.0506	CbGpPWpGaD
Raltitrexed—Tetrahydrofolic acid—ATIC—osteoporosis	0.0106	0.282	CrCbGaD
Raltitrexed—TYMS—Nucleotide metabolism—PNP—osteoporosis	0.00811	0.0354	CbGpPWpGaD
Raltitrexed—TYMS—Nucleotide metabolism—ATIC—osteoporosis	0.00811	0.0354	CbGpPWpGaD
Raltitrexed—Methotrexate—ATIC—osteoporosis	0.00727	0.193	CrCbGaD
Raltitrexed—TYMS—Circadian rythm related genes—ID4—osteoporosis	0.00724	0.0316	CbGpPWpGaD
Raltitrexed—TYMS—Levorphanol—Estradiol—osteoporosis	0.00588	0.469	CbGdCrCtD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.00533	0.0233	CbGpPWpGaD
Raltitrexed—TYMS—One Carbon Metabolism—MTHFR—osteoporosis	0.00481	0.021	CbGpPWpGaD
Raltitrexed—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00433	0.0189	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00422	0.0184	CbGpPWpGaD
Raltitrexed—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.00388	0.309	CbGdCrCtD
Raltitrexed—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00278	0.222	CbGdCrCtD
Raltitrexed—FPGS—Disease—PKM—osteoporosis	0.00278	0.0122	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SOST—osteoporosis	0.00278	0.0122	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—PSMA2—osteoporosis	0.00266	0.0116	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—PSMA5—osteoporosis	0.00266	0.0116	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PGLS—osteoporosis	0.00264	0.0115	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ANTXR2—osteoporosis	0.00264	0.0115	CbGpPWpGaD
Raltitrexed—Tetrahydrofolic acid—MTHFR—osteoporosis	0.00245	0.0652	CrCbGaD
Raltitrexed—Folic Acid—MTHFR—osteoporosis	0.00245	0.0652	CrCbGaD
Raltitrexed—FPGS—Metabolism—PKM—osteoporosis	0.00233	0.0102	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—FDPS—osteoporosis	0.00233	0.0102	CbGpPWpGaD
Raltitrexed—TYMS—Nucleotide metabolism—GPX1—osteoporosis	0.0023	0.01	CbGpPWpGaD
Raltitrexed—FPGS—Disease—GSN—osteoporosis	0.00224	0.0098	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00224	0.0098	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00224	0.0098	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PGLS—osteoporosis	0.00221	0.00966	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GPD2—osteoporosis	0.00221	0.00966	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00213	0.00932	CbGpPWpGaD
Raltitrexed—Discomfort—Ibandronate—osteoporosis	0.00212	0.00294	CcSEcCtD
Raltitrexed—Infection—Alendronate—osteoporosis	0.0021	0.00291	CcSEcCtD
Raltitrexed—Discomfort—Calcitriol—osteoporosis	0.00208	0.00288	CcSEcCtD
Raltitrexed—Infection—Raloxifene—osteoporosis	0.00207	0.00287	CcSEcCtD
Raltitrexed—Infection—Ibandronate—osteoporosis	0.00205	0.00284	CcSEcCtD
Raltitrexed—Feeling abnormal—Etidronic acid—osteoporosis	0.00205	0.00284	CcSEcCtD
Raltitrexed—Thrombocytopenia—Raloxifene—osteoporosis	0.00204	0.00283	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00203	0.00282	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PNP—osteoporosis	0.00202	0.00883	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ATIC—osteoporosis	0.00202	0.00883	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Raloxifene—osteoporosis	0.00201	0.00279	CcSEcCtD
Raltitrexed—Alopecia—Pamidronate—osteoporosis	0.00201	0.00278	CcSEcCtD
Raltitrexed—Hyperhidrosis—Ibandronate—osteoporosis	0.00199	0.00276	CcSEcCtD
Raltitrexed—Nausea—Ergocalciferol—osteoporosis	0.00198	0.00275	CcSEcCtD
Raltitrexed—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.00198	0.00275	CcSEcCtD
Raltitrexed—Abdominal pain—Etidronic acid—osteoporosis	0.00196	0.00272	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00196	0.00271	CcSEcCtD
Raltitrexed—FPGS—Disease—LRP5—osteoporosis	0.00195	0.00853	CbGpPWpGaD
Raltitrexed—Dysgeusia—Pamidronate—osteoporosis	0.00194	0.00269	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00193	0.00267	CcSEcCtD
Raltitrexed—Malaise—Ethinyl Estradiol—osteoporosis	0.00192	0.00267	CcSEcCtD
Raltitrexed—Anaemia—Risedronate—osteoporosis	0.00192	0.00267	CcSEcCtD
Raltitrexed—Anorexia—Calcitriol—osteoporosis	0.00192	0.00267	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.0019	0.00263	CcSEcCtD
Raltitrexed—Dyspepsia—Estropipate—osteoporosis	0.00189	0.00262	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00188	0.0026	CcSEcCtD
Raltitrexed—FPGS—Disease—LRP6—osteoporosis	0.00187	0.00816	CbGpPWpGaD
Raltitrexed—Dyspepsia—Alendronate—osteoporosis	0.00186	0.00258	CcSEcCtD
Raltitrexed—Cough—Ethinyl Estradiol—osteoporosis	0.00186	0.00258	CcSEcCtD
Raltitrexed—Arrhythmia—Zoledronate—osteoporosis	0.00185	0.00257	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00184	0.00255	CcSEcCtD
Raltitrexed—Pain—Estropipate—osteoporosis	0.00184	0.00255	CcSEcCtD
Raltitrexed—Constipation—Estropipate—osteoporosis	0.00184	0.00255	CcSEcCtD
Raltitrexed—Ill-defined disorder—Pamidronate—osteoporosis	0.00183	0.00254	CcSEcCtD
Raltitrexed—Alopecia—Zoledronate—osteoporosis	0.00183	0.00254	CcSEcCtD
Raltitrexed—Dyspepsia—Raloxifene—osteoporosis	0.00183	0.00254	CcSEcCtD
Raltitrexed—Anaemia—Pamidronate—osteoporosis	0.00183	0.00253	CcSEcCtD
Raltitrexed—Cough—Risedronate—osteoporosis	0.00181	0.00252	CcSEcCtD
Raltitrexed—Dyspepsia—Ibandronate—osteoporosis	0.00181	0.00251	CcSEcCtD
Raltitrexed—Constipation—Alendronate—osteoporosis	0.00181	0.00251	CcSEcCtD
Raltitrexed—Pain—Alendronate—osteoporosis	0.00181	0.00251	CcSEcCtD
Raltitrexed—Weight decreased—Estradiol—osteoporosis	0.00181	0.00251	CcSEcCtD
Raltitrexed—Discomfort—Ethinyl Estradiol—osteoporosis	0.00179	0.00249	CcSEcCtD
Raltitrexed—FPGS—Disease—LTF—osteoporosis	0.00179	0.00784	CbGpPWpGaD
Raltitrexed—FPGS—Disease—RPL24—osteoporosis	0.00179	0.00784	CbGpPWpGaD
Raltitrexed—Decreased appetite—Ibandronate—osteoporosis	0.00179	0.00248	CcSEcCtD
Raltitrexed—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00178	0.00248	CcSEcCtD
Raltitrexed—Malaise—Pamidronate—osteoporosis	0.00178	0.00247	CcSEcCtD
Raltitrexed—Pain—Raloxifene—osteoporosis	0.00178	0.00247	CcSEcCtD
Raltitrexed—Arthralgia—Risedronate—osteoporosis	0.00177	0.00246	CcSEcCtD
Raltitrexed—Leukopenia—Pamidronate—osteoporosis	0.00177	0.00245	CcSEcCtD
Raltitrexed—Dysgeusia—Zoledronate—osteoporosis	0.00177	0.00245	CcSEcCtD
Raltitrexed—Alopecia—Conjugated Estrogens—osteoporosis	0.00176	0.00245	CcSEcCtD
Raltitrexed—Pain—Ibandronate—osteoporosis	0.00176	0.00244	CcSEcCtD
Raltitrexed—Constipation—Ibandronate—osteoporosis	0.00176	0.00244	CcSEcCtD
Raltitrexed—Pruritus—Etidronic acid—osteoporosis	0.00176	0.00244	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Estropipate—osteoporosis	0.00176	0.00244	CcSEcCtD
Raltitrexed—Decreased appetite—Calcitriol—osteoporosis	0.00175	0.00243	CcSEcCtD
Raltitrexed—Feeling abnormal—Alendronate—osteoporosis	0.00174	0.00242	CcSEcCtD
Raltitrexed—Oedema—Ethinyl Estradiol—osteoporosis	0.00174	0.00241	CcSEcCtD
Raltitrexed—Conjunctivitis—Estradiol—osteoporosis	0.00173	0.0024	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Alendronate—osteoporosis	0.00173	0.0024	CcSEcCtD
Raltitrexed—Infection—Ethinyl Estradiol—osteoporosis	0.00173	0.0024	CcSEcCtD
Raltitrexed—Cough—Pamidronate—osteoporosis	0.00173	0.00239	CcSEcCtD
Raltitrexed—Pain—Calcitriol—osteoporosis	0.00172	0.00239	CcSEcCtD
Raltitrexed—Constipation—Calcitriol—osteoporosis	0.00172	0.00239	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CA2—osteoporosis	0.00172	0.00751	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—OXCT1—osteoporosis	0.00172	0.00751	CbGpPWpGaD
Raltitrexed—Dysgeusia—Conjugated Estrogens—osteoporosis	0.0017	0.00236	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Raloxifene—osteoporosis	0.0017	0.00236	CcSEcCtD
Raltitrexed—Diarrhoea—Etidronic acid—osteoporosis	0.0017	0.00236	CcSEcCtD
Raltitrexed—Abdominal pain—Estropipate—osteoporosis	0.0017	0.00235	CcSEcCtD
Raltitrexed—Body temperature increased—Estropipate—osteoporosis	0.0017	0.00235	CcSEcCtD
Raltitrexed—Feeling abnormal—Ibandronate—osteoporosis	0.0017	0.00235	CcSEcCtD
Raltitrexed—Infection—Risedronate—osteoporosis	0.00169	0.00234	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Ibandronate—osteoporosis	0.00168	0.00234	CcSEcCtD
Raltitrexed—Arthralgia—Pamidronate—osteoporosis	0.00168	0.00233	CcSEcCtD
Raltitrexed—Methotrexate—MTHFR—osteoporosis	0.00168	0.0446	CrCbGaD
Raltitrexed—Ill-defined disorder—Zoledronate—osteoporosis	0.00168	0.00232	CcSEcCtD
Raltitrexed—FPGS—Metabolism—MGLL—osteoporosis	0.00168	0.00732	CbGpPWpGaD
Raltitrexed—Body temperature increased—Alendronate—osteoporosis	0.00167	0.00232	CcSEcCtD
Raltitrexed—Abdominal pain—Alendronate—osteoporosis	0.00167	0.00232	CcSEcCtD
Raltitrexed—Anaemia—Zoledronate—osteoporosis	0.00167	0.00232	CcSEcCtD
Raltitrexed—Discomfort—Pamidronate—osteoporosis	0.00166	0.00231	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Calcitriol—osteoporosis	0.00165	0.00229	CcSEcCtD
Raltitrexed—Abdominal pain—Raloxifene—osteoporosis	0.00164	0.00228	CcSEcCtD
Raltitrexed—Body temperature increased—Raloxifene—osteoporosis	0.00164	0.00228	CcSEcCtD
Raltitrexed—Malaise—Zoledronate—osteoporosis	0.00163	0.00226	CcSEcCtD
Raltitrexed—Abdominal pain—Ibandronate—osteoporosis	0.00163	0.00226	CcSEcCtD
Raltitrexed—Body temperature increased—Ibandronate—osteoporosis	0.00163	0.00226	CcSEcCtD
Raltitrexed—Leukopenia—Zoledronate—osteoporosis	0.00162	0.00224	CcSEcCtD
Raltitrexed—Oedema—Pamidronate—osteoporosis	0.00161	0.00224	CcSEcCtD
Raltitrexed—Infection—Pamidronate—osteoporosis	0.0016	0.00222	CcSEcCtD
Raltitrexed—Abdominal pain—Calcitriol—osteoporosis	0.00159	0.00221	CcSEcCtD
Raltitrexed—Body temperature increased—Calcitriol—osteoporosis	0.00159	0.00221	CcSEcCtD
Raltitrexed—Thrombocytopenia—Pamidronate—osteoporosis	0.00158	0.00219	CcSEcCtD
Raltitrexed—Vomiting—Etidronic acid—osteoporosis	0.00158	0.00219	CcSEcCtD
Raltitrexed—Cough—Zoledronate—osteoporosis	0.00158	0.00219	CcSEcCtD
Raltitrexed—Rash—Etidronic acid—osteoporosis	0.00157	0.00217	CcSEcCtD
Raltitrexed—Dermatitis—Etidronic acid—osteoporosis	0.00156	0.00217	CcSEcCtD
Raltitrexed—Hyperhidrosis—Pamidronate—osteoporosis	0.00156	0.00216	CcSEcCtD
Raltitrexed—FPGS—Disease—ACP5—osteoporosis	0.00156	0.0068	CbGpPWpGaD
Raltitrexed—Headache—Etidronic acid—osteoporosis	0.00156	0.00216	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00155	0.00214	CcSEcCtD
Raltitrexed—Asthenia—Estropipate—osteoporosis	0.00154	0.00214	CcSEcCtD
Raltitrexed—Anorexia—Pamidronate—osteoporosis	0.00154	0.00213	CcSEcCtD
Raltitrexed—Arthralgia—Zoledronate—osteoporosis	0.00154	0.00213	CcSEcCtD
Raltitrexed—Pruritus—Estropipate—osteoporosis	0.00152	0.00211	CcSEcCtD
Raltitrexed—Discomfort—Zoledronate—osteoporosis	0.00152	0.00211	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00152	0.00663	CbGpPWpGaD
Raltitrexed—Asthenia—Alendronate—osteoporosis	0.00152	0.00211	CcSEcCtD
Raltitrexed—Cough—Conjugated Estrogens—osteoporosis	0.00152	0.0021	CcSEcCtD
Raltitrexed—Pruritus—Alendronate—osteoporosis	0.0015	0.00208	CcSEcCtD
Raltitrexed—Dyspepsia—Risedronate—osteoporosis	0.00149	0.00207	CcSEcCtD
Raltitrexed—Constipation—Ethinyl Estradiol—osteoporosis	0.00149	0.00206	CcSEcCtD
Raltitrexed—Arthralgia—Conjugated Estrogens—osteoporosis	0.00148	0.00205	CcSEcCtD
Raltitrexed—Asthenia—Ibandronate—osteoporosis	0.00148	0.00205	CcSEcCtD
Raltitrexed—Nausea—Etidronic acid—osteoporosis	0.00147	0.00205	CcSEcCtD
Raltitrexed—Oedema—Zoledronate—osteoporosis	0.00147	0.00204	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00147	0.00204	CcSEcCtD
Raltitrexed—Diarrhoea—Estropipate—osteoporosis	0.00147	0.00204	CcSEcCtD
Raltitrexed—Infection—Zoledronate—osteoporosis	0.00146	0.00203	CcSEcCtD
Raltitrexed—Pruritus—Ibandronate—osteoporosis	0.00146	0.00202	CcSEcCtD
Raltitrexed—Pain—Risedronate—osteoporosis	0.00145	0.00201	CcSEcCtD
Raltitrexed—Constipation—Risedronate—osteoporosis	0.00145	0.00201	CcSEcCtD
Raltitrexed—Diarrhoea—Alendronate—osteoporosis	0.00145	0.00201	CcSEcCtD
Raltitrexed—Asthenia—Calcitriol—osteoporosis	0.00145	0.00201	CcSEcCtD
Raltitrexed—FPGS—Disease—TPI1—osteoporosis	0.00145	0.00632	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Zoledronate—osteoporosis	0.00144	0.002	CcSEcCtD
Raltitrexed—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00143	0.00199	CcSEcCtD
Raltitrexed—Pruritus—Calcitriol—osteoporosis	0.00143	0.00198	CcSEcCtD
Raltitrexed—Hyperhidrosis—Zoledronate—osteoporosis	0.00142	0.00198	CcSEcCtD
Raltitrexed—FPGS—Metabolism—IDH2—osteoporosis	0.00142	0.00622	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00142	0.00197	CcSEcCtD
Raltitrexed—Diarrhoea—Raloxifene—osteoporosis	0.00142	0.00197	CcSEcCtD
Raltitrexed—Dyspepsia—Pamidronate—osteoporosis	0.00142	0.00197	CcSEcCtD
Raltitrexed—Oedema—Conjugated Estrogens—osteoporosis	0.00142	0.00197	CcSEcCtD
Raltitrexed—Alopecia—Estradiol—osteoporosis	0.00141	0.00196	CcSEcCtD
Raltitrexed—Infection—Conjugated Estrogens—osteoporosis	0.00141	0.00196	CcSEcCtD
Raltitrexed—Diarrhoea—Ibandronate—osteoporosis	0.00141	0.00195	CcSEcCtD
Raltitrexed—Anorexia—Zoledronate—osteoporosis	0.0014	0.00195	CcSEcCtD
Raltitrexed—Decreased appetite—Pamidronate—osteoporosis	0.0014	0.00195	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Risedronate—osteoporosis	0.00139	0.00193	CcSEcCtD
Raltitrexed—Constipation—Pamidronate—osteoporosis	0.00138	0.00191	CcSEcCtD
Raltitrexed—Pain—Pamidronate—osteoporosis	0.00138	0.00191	CcSEcCtD
Raltitrexed—Diarrhoea—Calcitriol—osteoporosis	0.00138	0.00191	CcSEcCtD
Raltitrexed—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00138	0.00191	CcSEcCtD
Raltitrexed—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00138	0.00191	CcSEcCtD
Raltitrexed—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00137	0.0019	CcSEcCtD
Raltitrexed—Vomiting—Estropipate—osteoporosis	0.00137	0.00189	CcSEcCtD
Raltitrexed—Dysgeusia—Estradiol—osteoporosis	0.00136	0.00189	CcSEcCtD
Raltitrexed—FPGS—Disease—P4HB—osteoporosis	0.00136	0.00594	CbGpPWpGaD
Raltitrexed—Rash—Estropipate—osteoporosis	0.00135	0.00188	CcSEcCtD
Raltitrexed—Dermatitis—Estropipate—osteoporosis	0.00135	0.00188	CcSEcCtD
Raltitrexed—Anorexia—Conjugated Estrogens—osteoporosis	0.00135	0.00188	CcSEcCtD
Raltitrexed—Headache—Estropipate—osteoporosis	0.00135	0.00187	CcSEcCtD
Raltitrexed—Vomiting—Alendronate—osteoporosis	0.00134	0.00187	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00134	0.00186	CcSEcCtD
Raltitrexed—Abdominal pain—Risedronate—osteoporosis	0.00134	0.00186	CcSEcCtD
Raltitrexed—Body temperature increased—Risedronate—osteoporosis	0.00134	0.00186	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP27A1—osteoporosis	0.00134	0.00585	CbGpPWpGaD
Raltitrexed—FPGS—Disease—GAPDH—osteoporosis	0.00133	0.00583	CbGpPWpGaD
Raltitrexed—Rash—Alendronate—osteoporosis	0.00133	0.00185	CcSEcCtD
Raltitrexed—Dermatitis—Alendronate—osteoporosis	0.00133	0.00185	CcSEcCtD
Raltitrexed—Feeling abnormal—Pamidronate—osteoporosis	0.00133	0.00184	CcSEcCtD
Raltitrexed—Headache—Alendronate—osteoporosis	0.00133	0.00184	CcSEcCtD
Raltitrexed—Vomiting—Raloxifene—osteoporosis	0.00132	0.00183	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Pamidronate—osteoporosis	0.00132	0.00183	CcSEcCtD
Raltitrexed—Rash—Raloxifene—osteoporosis	0.00131	0.00182	CcSEcCtD
Raltitrexed—Dermatitis—Raloxifene—osteoporosis	0.00131	0.00182	CcSEcCtD
Raltitrexed—Vomiting—Ibandronate—osteoporosis	0.00131	0.00182	CcSEcCtD
Raltitrexed—Headache—Raloxifene—osteoporosis	0.0013	0.00181	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ACP5—osteoporosis	0.0013	0.00569	CbGpPWpGaD
Raltitrexed—Rash—Ibandronate—osteoporosis	0.0013	0.0018	CcSEcCtD
Raltitrexed—Dermatitis—Ibandronate—osteoporosis	0.0013	0.0018	CcSEcCtD
Raltitrexed—Dyspepsia—Zoledronate—osteoporosis	0.0013	0.0018	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00129	0.00179	CcSEcCtD
Raltitrexed—Ill-defined disorder—Estradiol—osteoporosis	0.00129	0.00179	CcSEcCtD
Raltitrexed—Headache—Ibandronate—osteoporosis	0.00129	0.00179	CcSEcCtD
Raltitrexed—Vomiting—Calcitriol—osteoporosis	0.00128	0.00178	CcSEcCtD
Raltitrexed—Decreased appetite—Zoledronate—osteoporosis	0.00128	0.00178	CcSEcCtD
Raltitrexed—Nausea—Estropipate—osteoporosis	0.00128	0.00177	CcSEcCtD
Raltitrexed—Body temperature increased—Pamidronate—osteoporosis	0.00128	0.00177	CcSEcCtD
Raltitrexed—Abdominal pain—Pamidronate—osteoporosis	0.00128	0.00177	CcSEcCtD
Raltitrexed—Rash—Calcitriol—osteoporosis	0.00127	0.00176	CcSEcCtD
Raltitrexed—Dermatitis—Calcitriol—osteoporosis	0.00127	0.00176	CcSEcCtD
Raltitrexed—FPGS—Disease—NFATC1—osteoporosis	0.00127	0.00554	CbGpPWpGaD
Raltitrexed—Headache—Calcitriol—osteoporosis	0.00126	0.00175	CcSEcCtD
Raltitrexed—Constipation—Zoledronate—osteoporosis	0.00126	0.00175	CcSEcCtD
Raltitrexed—Pain—Zoledronate—osteoporosis	0.00126	0.00175	CcSEcCtD
Raltitrexed—FPGS—Disease—DKK1—osteoporosis	0.00126	0.0055	CbGpPWpGaD
Raltitrexed—Nausea—Alendronate—osteoporosis	0.00126	0.00174	CcSEcCtD
Raltitrexed—Malaise—Estradiol—osteoporosis	0.00125	0.00174	CcSEcCtD
Raltitrexed—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00125	0.00173	CcSEcCtD
Raltitrexed—Asthenia—Ethinyl Estradiol—osteoporosis	0.00125	0.00173	CcSEcCtD
Raltitrexed—Nausea—Raloxifene—osteoporosis	0.00124	0.00171	CcSEcCtD
Raltitrexed—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00123	0.00171	CcSEcCtD
Raltitrexed—Pruritus—Ethinyl Estradiol—osteoporosis	0.00123	0.00171	CcSEcCtD
Raltitrexed—Nausea—Ibandronate—osteoporosis	0.00122	0.0017	CcSEcCtD
Raltitrexed—Asthenia—Risedronate—osteoporosis	0.00122	0.00169	CcSEcCtD
Raltitrexed—Feeling abnormal—Zoledronate—osteoporosis	0.00121	0.00168	CcSEcCtD
Raltitrexed—Cough—Estradiol—osteoporosis	0.00121	0.00168	CcSEcCtD
Raltitrexed—Constipation—Conjugated Estrogens—osteoporosis	0.00121	0.00168	CcSEcCtD
Raltitrexed—Pain—Conjugated Estrogens—osteoporosis	0.00121	0.00168	CcSEcCtD
Raltitrexed—FPGS—Disease—WNT1—osteoporosis	0.00121	0.00529	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—TPI1—osteoporosis	0.00121	0.00529	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Zoledronate—osteoporosis	0.00121	0.00167	CcSEcCtD
Raltitrexed—Pruritus—Risedronate—osteoporosis	0.0012	0.00167	CcSEcCtD
Raltitrexed—Nausea—Calcitriol—osteoporosis	0.0012	0.00166	CcSEcCtD
Raltitrexed—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00119	0.00165	CcSEcCtD
Raltitrexed—Arthralgia—Estradiol—osteoporosis	0.00118	0.00164	CcSEcCtD
Raltitrexed—FPGS—Disease—FGA—osteoporosis	0.00118	0.00515	CbGpPWpGaD
Raltitrexed—Discomfort—Estradiol—osteoporosis	0.00117	0.00162	CcSEcCtD
Raltitrexed—Abdominal pain—Zoledronate—osteoporosis	0.00116	0.00162	CcSEcCtD
Raltitrexed—Body temperature increased—Zoledronate—osteoporosis	0.00116	0.00162	CcSEcCtD
Raltitrexed—Diarrhoea—Risedronate—osteoporosis	0.00116	0.00161	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00116	0.00161	CcSEcCtD
Raltitrexed—Asthenia—Pamidronate—osteoporosis	0.00116	0.00161	CcSEcCtD
Raltitrexed—Pruritus—Pamidronate—osteoporosis	0.00114	0.00158	CcSEcCtD
Raltitrexed—FPGS—Metabolism—P4HB—osteoporosis	0.00114	0.00497	CbGpPWpGaD
Raltitrexed—Oedema—Estradiol—osteoporosis	0.00114	0.00158	CcSEcCtD
Raltitrexed—Infection—Estradiol—osteoporosis	0.00113	0.00157	CcSEcCtD
Raltitrexed—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00112	0.00156	CcSEcCtD
Raltitrexed—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00112	0.00156	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GAPDH—osteoporosis	0.00112	0.00488	CbGpPWpGaD
Raltitrexed—Vomiting—Ethinyl Estradiol—osteoporosis	0.00111	0.00154	CcSEcCtD
Raltitrexed—Diarrhoea—Pamidronate—osteoporosis	0.0011	0.00153	CcSEcCtD
Raltitrexed—Hyperhidrosis—Estradiol—osteoporosis	0.0011	0.00152	CcSEcCtD
Raltitrexed—Rash—Ethinyl Estradiol—osteoporosis	0.0011	0.00152	CcSEcCtD
Raltitrexed—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0011	0.00152	CcSEcCtD
Raltitrexed—Headache—Ethinyl Estradiol—osteoporosis	0.00109	0.00151	CcSEcCtD
Raltitrexed—FPGS—Metabolism—RAP1A—osteoporosis	0.00109	0.00476	CbGpPWpGaD
Raltitrexed—Vomiting—Risedronate—osteoporosis	0.00108	0.0015	CcSEcCtD
Raltitrexed—Rash—Risedronate—osteoporosis	0.00107	0.00148	CcSEcCtD
Raltitrexed—Dermatitis—Risedronate—osteoporosis	0.00107	0.00148	CcSEcCtD
Raltitrexed—Headache—Risedronate—osteoporosis	0.00106	0.00147	CcSEcCtD
Raltitrexed—Asthenia—Zoledronate—osteoporosis	0.00106	0.00147	CcSEcCtD
Raltitrexed—FPGS—Disease—ENO1—osteoporosis	0.00105	0.00459	CbGpPWpGaD
Raltitrexed—Pruritus—Zoledronate—osteoporosis	0.00104	0.00145	CcSEcCtD
Raltitrexed—FPGS—Disease—PSMA2—osteoporosis	0.00104	0.00452	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PSMA5—osteoporosis	0.00104	0.00452	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00103	0.00144	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—MYC—osteoporosis	0.00103	0.00452	CbGpPWpGaD
Raltitrexed—Nausea—Ethinyl Estradiol—osteoporosis	0.00103	0.00143	CcSEcCtD
Raltitrexed—Vomiting—Pamidronate—osteoporosis	0.00103	0.00142	CcSEcCtD
Raltitrexed—Asthenia—Conjugated Estrogens—osteoporosis	0.00102	0.00141	CcSEcCtD
Raltitrexed—Rash—Pamidronate—osteoporosis	0.00102	0.00141	CcSEcCtD
Raltitrexed—Dermatitis—Pamidronate—osteoporosis	0.00102	0.00141	CcSEcCtD
Raltitrexed—Headache—Pamidronate—osteoporosis	0.00101	0.0014	CcSEcCtD
Raltitrexed—Diarrhoea—Zoledronate—osteoporosis	0.00101	0.0014	CcSEcCtD
Raltitrexed—Nausea—Risedronate—osteoporosis	0.00101	0.0014	CcSEcCtD
Raltitrexed—Pruritus—Conjugated Estrogens—osteoporosis	0.001	0.00139	CcSEcCtD
Raltitrexed—Dyspepsia—Estradiol—osteoporosis	0.001	0.00139	CcSEcCtD
Raltitrexed—Decreased appetite—Estradiol—osteoporosis	0.000987	0.00137	CcSEcCtD
Raltitrexed—Pain—Estradiol—osteoporosis	0.000971	0.00135	CcSEcCtD
Raltitrexed—Constipation—Estradiol—osteoporosis	0.000971	0.00135	CcSEcCtD
Raltitrexed—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000971	0.00135	CcSEcCtD
Raltitrexed—FPGS—Disease—CALCA—osteoporosis	0.000965	0.00422	CbGpPWpGaD
Raltitrexed—Nausea—Pamidronate—osteoporosis	0.000958	0.00133	CcSEcCtD
Raltitrexed—Vomiting—Zoledronate—osteoporosis	0.000937	0.0013	CcSEcCtD
Raltitrexed—Feeling abnormal—Estradiol—osteoporosis	0.000936	0.0013	CcSEcCtD
Raltitrexed—Rash—Zoledronate—osteoporosis	0.000929	0.00129	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Estradiol—osteoporosis	0.000929	0.00129	CcSEcCtD
Raltitrexed—Dermatitis—Zoledronate—osteoporosis	0.000928	0.00129	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.000926	0.00405	CbGpPWpGaD
Raltitrexed—Headache—Zoledronate—osteoporosis	0.000923	0.00128	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000921	0.00402	CbGpPWpGaD
Raltitrexed—Vomiting—Conjugated Estrogens—osteoporosis	0.000902	0.00125	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000899	0.00393	CbGpPWpGaD
Raltitrexed—Abdominal pain—Estradiol—osteoporosis	0.000898	0.00125	CcSEcCtD
Raltitrexed—Body temperature increased—Estradiol—osteoporosis	0.000898	0.00125	CcSEcCtD
Raltitrexed—Rash—Conjugated Estrogens—osteoporosis	0.000895	0.00124	CcSEcCtD
Raltitrexed—Dermatitis—Conjugated Estrogens—osteoporosis	0.000894	0.00124	CcSEcCtD
Raltitrexed—Headache—Conjugated Estrogens—osteoporosis	0.000889	0.00123	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ENO1—osteoporosis	0.00088	0.00384	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KL—osteoporosis	0.000876	0.00383	CbGpPWpGaD
Raltitrexed—Nausea—Zoledronate—osteoporosis	0.000875	0.00121	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PSMA5—osteoporosis	0.000867	0.00379	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PSMA2—osteoporosis	0.000867	0.00379	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PKM—osteoporosis	0.00085	0.00371	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—FDPS—osteoporosis	0.00085	0.00371	CbGpPWpGaD
Raltitrexed—Nausea—Conjugated Estrogens—osteoporosis	0.000843	0.00117	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000823	0.00359	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000823	0.00359	CbGpPWpGaD
Raltitrexed—Asthenia—Estradiol—osteoporosis	0.000815	0.00113	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GPD2—osteoporosis	0.000806	0.00352	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PGLS—osteoporosis	0.000806	0.00352	CbGpPWpGaD
Raltitrexed—Pruritus—Estradiol—osteoporosis	0.000804	0.00111	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000797	0.00348	CbGpPWpGaD
Raltitrexed—Diarrhoea—Estradiol—osteoporosis	0.000777	0.00108	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—osteoporosis	0.00075	0.00328	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ATIC—osteoporosis	0.000737	0.00322	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PNP—osteoporosis	0.000737	0.00322	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—PSMA2—osteoporosis	0.000736	0.00321	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—PSMA5—osteoporosis	0.000736	0.00321	CbGpPWpGaD
Raltitrexed—Vomiting—Estradiol—osteoporosis	0.000722	0.001	CcSEcCtD
Raltitrexed—Rash—Estradiol—osteoporosis	0.000716	0.000993	CcSEcCtD
Raltitrexed—Dermatitis—Estradiol—osteoporosis	0.000715	0.000992	CcSEcCtD
Raltitrexed—Headache—Estradiol—osteoporosis	0.000711	0.000987	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP19A1—osteoporosis	0.000703	0.00307	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ADCY5—osteoporosis	0.000686	0.003	CbGpPWpGaD
Raltitrexed—Nausea—Estradiol—osteoporosis	0.000675	0.000936	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000632	0.00276	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTHFR—osteoporosis	0.000631	0.00276	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—OXCT1—osteoporosis	0.000627	0.00274	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA2—osteoporosis	0.000627	0.00274	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MGLL—osteoporosis	0.000611	0.00267	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IRS2—osteoporosis	0.0006	0.00262	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ADCY5—osteoporosis	0.000575	0.00251	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GPX1—osteoporosis	0.000573	0.0025	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTHFR—osteoporosis	0.000529	0.00231	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IRS1—osteoporosis	0.000524	0.00229	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—IDH2—osteoporosis	0.000519	0.00227	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6R—osteoporosis	0.000492	0.00215	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP27A1—osteoporosis	0.000488	0.00213	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000479	0.00209	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000478	0.00209	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ACP5—osteoporosis	0.000475	0.00207	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000446	0.00195	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TPI1—osteoporosis	0.000441	0.00193	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—POMC—osteoporosis	0.000423	0.00185	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—P4HB—osteoporosis	0.000415	0.00181	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GAPDH—osteoporosis	0.000407	0.00178	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—RAP1A—osteoporosis	0.000397	0.00173	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—osteoporosis	0.000346	0.00151	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ENO1—osteoporosis	0.000321	0.0014	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PSMA5—osteoporosis	0.000316	0.00138	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PSMA2—osteoporosis	0.000316	0.00138	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—osteoporosis	0.000292	0.00127	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—osteoporosis	0.000291	0.00127	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP19A1—osteoporosis	0.000256	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	0.000232	0.00101	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6—osteoporosis	0.000219	0.000958	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ADCY5—osteoporosis	0.00021	0.000915	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GPX1—osteoporosis	0.000209	0.000912	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—osteoporosis	0.000207	0.000906	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—osteoporosis	0.000193	0.000842	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—POMC—osteoporosis	0.000154	0.000673	CbGpPWpGaD
